Ashlyn Holstein Savage, MD | |
171 Ashley Ave, Charleston, SC 29425-0001 | |
(843) 792-1414 | |
Not Available |
Full Name | Ashlyn Holstein Savage |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 22 Years |
Location | 171 Ashley Ave, Charleston, South Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013940089 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | TL28714 (South Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Musc Medical Center | Charleston, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
A new approach for generating large numbers of circulatory system cells, known as vascular endothelial cells (VECs), from human amniotic-fluid-derived cells (ACs) is reported in a study published by Cell Press October 18th in the journal Cell. The strategy, which shows promise in mice, opens the door to establishing a vast inventory of VECs for promoting organ regeneration and treating diverse vascular disorders.
News outlets report on the employer health insurance market.
Researchers in the Perelman School of Medicine at the University of Pennsylvania have determined the role of a key growth factor, found in skin cells of limited quantities in humans, which helps hair follicles form and regenerate during the wound healing process.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
› Verified 2 days ago
Entity Name | University Medical Associates Of The Medical University Of South Carol |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
A new approach for generating large numbers of circulatory system cells, known as vascular endothelial cells (VECs), from human amniotic-fluid-derived cells (ACs) is reported in a study published by Cell Press October 18th in the journal Cell. The strategy, which shows promise in mice, opens the door to establishing a vast inventory of VECs for promoting organ regeneration and treating diverse vascular disorders.
News outlets report on the employer health insurance market.
Researchers in the Perelman School of Medicine at the University of Pennsylvania have determined the role of a key growth factor, found in skin cells of limited quantities in humans, which helps hair follicles form and regenerate during the wound healing process.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Ashlyn Holstein Savage, MD Po Box 751461, Charlotte, NC 28275-1461 Ph: (843) 792-6200 | Ashlyn Holstein Savage, MD 171 Ashley Ave, Charleston, SC 29425-0001 Ph: (843) 792-1414 |
News Archive
A new approach for generating large numbers of circulatory system cells, known as vascular endothelial cells (VECs), from human amniotic-fluid-derived cells (ACs) is reported in a study published by Cell Press October 18th in the journal Cell. The strategy, which shows promise in mice, opens the door to establishing a vast inventory of VECs for promoting organ regeneration and treating diverse vascular disorders.
News outlets report on the employer health insurance market.
Researchers in the Perelman School of Medicine at the University of Pennsylvania have determined the role of a key growth factor, found in skin cells of limited quantities in humans, which helps hair follicles form and regenerate during the wound healing process.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
› Verified 2 days ago
Bethany Anne Bruno, MD, MA Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-2300 | |
Matthew Kohler, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Elsa C Caire, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2097 Henry Tecklenburg Dr, Suite 312w, Charleston, SC 29414 Phone: 843-769-5620 Fax: 843-769-5625 | |
Paula E Orr, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5319 Parkshire Way, Charleston, SC 29418 Phone: 843-767-2121 Fax: 843-767-2102 | |
Monica June Mitchum, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1027 Physicians Dr Ste 110, Charleston, SC 29414 Phone: 843-740-6700 Fax: 843-745-9428 | |
Phillip Andres Rodriguez, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-7108 |